Inactive

PRE-SOLICITATION NOTICE NOI-NIAID-2124003 NAICS – 811219 This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Insti... PRE-SOLICITATION NOTICE NOI-NIAID-2124003 NAICS – 811219 This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Sartorius Corporation to procure a 1-year service and maintenance plan for a Sartorius Intellicyt iQue3 Flow Cytometry System: IQUE3 VBR, S/N: 3151, PRODUCT # 50120. The Antibody Biology Unit (ABU) of the Laboratory of Immunogenetics (LIG) within NIH, in furtherance of its mission to advance the knowledge of human B cells cells and isolation of monoclonal antibodies, requires the iQue3 to be operational at all times. It is currently being used for COVID research, to identify potent monoclonal antibodies against SARS-CoV-2. The Sartorius Intellicyt iQue 3 system is manufactured by Essen BioScience, a Sartorius Company, and Sartorius is the only company that provides service on this equipment due to its proprietary rights to the hardware and software. One of the key features of the iQue3 platform is the ForeCyt Software which delivers a fully integrated experience, from data acquisition to plate-level analytics and multi-parametric data visualization and provides multi-user access and multi-instrument data management. Software upgrades and constant system operation are vital for NIH and required for essential work, therefore, continuous maintenance and on-call service technicians are imperative to the instrument’s operation. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (e) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2124003) to Dana Monroe at dana.monroe@nih.gov, by Sunday, April 24, 2022 by 5:00pm pacific time. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.